Dr. Timos Papagatsias’ Post

Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines

4mo

Thoughts on this? >> Neumora announces clinical hold from FDA on Phase 1 study for schizophrenia drug >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #productmarketing #biotech

FDA hits Neumora with clinical hold for schizophrenia drug after preclinical data showed convulsions in rabbits

FDA hits Neumora with clinical hold for schizophrenia drug after preclinical data showed convulsions in rabbits

https://endpts.com

To view or add a comment, sign in

More Relevant Posts

Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
7mo
Report this post
EMD Serono lays out MS therapies' immune-system suppression risks in new campaign >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #pharmaceutical #productmarketing

EMD Serono lays out MS therapies' immune-system suppression risks in new campaign

https://endpts.com
Like Comment
To view or add a comment, sign in
LucidQuest

6,213 followers
4mo
Report this post
Thoughts on this? >> Biosplice searches for a path forward after osteoarthritis drug fails late-stage study >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #healthcare #pharmaceutical #productmarketing

Biosplice searches for a path forward after osteoarthritis drug fails late-stage study

https://endpts.com
Like Comment
To view or add a comment, sign in
Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
5mo
Report this post
Thoughts on this? >> Crinetics reports second PhIII win for acromegaly drug, eyes 2025 launch >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #pharma #biotech

Crinetics reports second PhIII win for acromegaly drug, eyes 2025 launch

https://endpts.com
Like Comment
To view or add a comment, sign in
Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
5mo
Report this post
Thoughts on this? >> FDA approves Merck's rare PAH drug at center of $11.5B Acceleron deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #productmarketing #pharma

FDA approves Merck's rare PAH drug at center of $11.5B Acceleron deal

https://endpts.com
Like Comment
To view or add a comment, sign in
LucidQuest

6,213 followers
5mo
Report this post
Thoughts on this? >> FDA approves Merck's rare PAH drug at center of $11.5B Acceleron deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #productmarketing #pharma #biotech

FDA approves Merck's rare PAH drug at center of $11.5B Acceleron deal

https://endpts.com
Like Comment
To view or add a comment, sign in
DrugPatentWatch Pharmaceutical Drug Patent Intelligence

1,912 followers
4mo
Report this post
AUGTYRO (repotrectinib) Drug Profile, 2024 P.S. If you like this post please 1) Like it (so I know it's useful) and 2) Repost and share it (so others can see it too)

AUGTYRO (repotrectinib) Drug Profile, 2024

https://www.drugpatentwatch.com/blog
Like Comment
To view or add a comment, sign in
LucidQuest

6,213 followers
5mo
Report this post
Thoughts on this? >> Crinetics reports second PhIII win for acromegaly drug, eyes 2025 launch >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #biotech #pharma

Crinetics reports second PhIII win for acromegaly drug, eyes 2025 launch

https://endpts.com
Like Comment
To view or add a comment, sign in
Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
4mo
Report this post
Thoughts on this? >> Biosplice searches for a path forward after osteoarthritis drug fails late-stage study >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #biotech #pharmaceutical #healthcare

Biosplice searches for a path forward after osteoarthritis drug fails late-stage study

https://endpts.com
Like Comment
To view or add a comment, sign in
Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
6mo
Report this post
Amgen’s MariTide to be tested in multiple obesity-related indications at PhIII >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #biotech #healthcare

As obesity market heats up, Amgen leaves clues on MariTide’s path forward

https://endpts.com
Like Comment
To view or add a comment, sign in
Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
3mo
Report this post
Thoughts on this? >> FDA lifts partial clinical hold on Larimar’s Friedreich’s ataxia treatment >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #healthcare #productmarketing

FDA lifts partial clinical hold on Larimar’s Friedreich’s ataxia treatment

https://endpts.com
Like Comment
To view or add a comment, sign in

Dr. Timos Papagatsias

24,068 followers

View Profile Follow

More from this author

Explore topics